Navigation Links
OpusClinicalSuite(R) Achieves 08 CCHIT Certification as Inpatient EHR
Date:6/25/2009

AUSTIN, Texas, June 25 /PRNewswire/ -- Opus Healthcare Solutions, Inc. announced today that OpusClinicalSuite(R) Version 2.3 has met the criteria set by the Certification Commission for Health Information Technology (CCHIT(R)) for receiving 08 Inpatient EHR certification. The certification is designated by CCHIT as pre-market conditional pending verified installation of the CCHIT Certified(R) version in an acute care hospital. CCHIT Certified product certification designates that a health information technology product has been tested against a set of functionality, interoperability and security criteria and has passed inspection of 100 percent of the criteria.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080325/LATU040LOGO)

As of June 25, 2009, Opus Healthcare is one of only two companies that currently have received CCHIT certification under the 08 criteria for this classification (see http://www.cchit.org/choose/inpatient/08/).

The Certification Commission for Healthcare Information Technology is a private non-profit organization recognized by the federal government as an official certification body for healthcare information technology (HIT) products. Their mission is to accelerate the adoption of robust, interoperable health information technology throughout the United States by creating an efficient, credible and sustainable certification program.

Tim Rhoads, Chief Executive Officer of Opus Healthcare Solutions, noted "We are very pleased to be a leader in the 08 CCHIT Certified Inpatient EHR category. The 08 criteria, the most current available, is rigorous and comprehensive. We believe that our 08 CCHIT certification will put us squarely on the short list of leading vendors offering certified products that will equi
'/>"/>

SOURCE Opus Healthcare Solutions, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Preferred Management Corp. Installs OpusClinicalSuite(R) at 2 Texas Hospitals
2. Bates County Memorial Hospital Selects Opus Healthcare Solutions, Inc. to Implement the OpusClinicalSuite(R) EMR
3. Kingfisher Healthcare (KFH) Achieves World Class Quality Platform
4. Kaiser Permanente Achieves Climate Action Leader Status
5. OSF HealthCare Achieves Impressive Tobacco Quit Rates with the Free & Clear(R) Quit For Life(TM) Program
6. LMS integrated obstetrics solution achieves general availability
7. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
8. Pharsight Achieves $7.3 Million in Quarterly Revenue
9. Halogen Software Achieves Most Successful Quarter in Company History - Includes Record Year-Over-Year Overall and License Revenue
10. Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia
11. Joint Commission International Achieves Accreditation from ISQua
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... News) -- Although cervical cancers are declining in the ... papillomavirus (HPV) are increasing, a new study indicates. ... the tongue and tonsils have increased over the past ... 45, the Canadian researchers report. "The increases in ... and of anal cancer among younger women are disturbing, ...
(Date:7/25/2014)... 2014 The Europe Cyber Security report ... Europe with analysis and forecast of revenue. This market ... 2014 to $19.07 billion by 2019, at a CAGR ... the TOC of the Europe Cyber Security Market report ... It also provides a glimpse of the segmentation in ...
(Date:7/25/2014)... American Brain Tumor Association (ABTA) today unveiled branding of ... patient and family conference in Chicago. , “This is ... we – the first and now only national organization ... tumor research – extend our reach by engaging volunteers ... our materials and services into the hands of those ...
(Date:7/25/2014)... Chicago, IL (PRWEB) July 25, 2014 Today, ... brain tumor, and yet, when it comes to pinpointing causes ... “Right now, we don’t know who, we don’t know when, ... Elizabeth M. Wilson, MNA, president & CEO, American Brain Tumor ... why the American Brain Tumor Association funds research to pursue ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 According to ... Substrate Wafer, Devices, Applications, and Geography - Analysis & ... by substrate is expected to reach $3.01 Billion by ... Sapphire Technology Market for devices is expected to reach ... that includes an in-depth analysis of application and geography. ...
Breaking Medicine News(10 mins):Health News:Anal, Throat Cancers on the Rise Among Young Adults, Study Finds 2Health News:Europe Cyber Security Market is Expected to Reach $19 billion in 2019 - New Report by MicroMarket Monitor 2Health News:Europe Cyber Security Market is Expected to Reach $19 billion in 2019 - New Report by MicroMarket Monitor 3Health News:Europe Cyber Security Market is Expected to Reach $19 billion in 2019 - New Report by MicroMarket Monitor 4Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 2Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 3Health News:Brain Tumor Causes and Risk Factors Elude Scientists 2Health News:Brain Tumor Causes and Risk Factors Elude Scientists 3Health News:Brain Tumor Causes and Risk Factors Elude Scientists 4Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 5Health News:Sapphire Technology Market Estimated to Reach $3.01 Billion by 2020 – New Report by MarketsandMarkets 6
... exposure causes genetic changes in breast cells , , THURSDAY, ... many plastic products used in households caused accelerated breast ... a condition that might predispose the animals to breast ... Butyl benzyl phthalate (BBP) is commonly used to soften ...
... occurrence in television shows and movies, but can watching it make ... Although research has shown ... there has been little direct neuroscientific support for this theory until ... Researchers at Columbia University Medical Centers Functional ...
... Program Sets Stage for Increased Visibility ... Among Shareholders and Investors, ... EMIS ) announced today that it has retained Adam,Friedman Associates, ... is a biopharmaceutical company that focuses on a,unique and improved ...
... Insmed Inc. (Nasdaq:,INSM), a developer of follow-on biologics and ... 5th Annual Global Follow-On Biologics,Conference on December 11, 2007 ... be held at the Hyatt Regency Hotel in Reston,Virginia, ... and will bring together corporate, regulatory, financial, and legal,experts ...
... SAN FRANCISCO, Calif., Dec. 6 Proteolix, Inc.,announced ... studies using,intravenous carfilzomib (PR-171) are to be presented ... Meeting in Atlanta, Georgia, December,8-10, 2007. Carfilzomib is ... for the treatment of multiple myeloma,lymphoma and solid ...
... SGX Pharmaceuticals, Inc.,(Nasdaq: SGXP ) announced today details of ... chronic myelogenous leukemia,(CML) at the upcoming American Society of Hematology,s ... 8th - 11th, 2007 in,Atlanta, Georgia., , The schedule ... Date: ...
Cached Medicine News:Health News:Common Household Chemical Could Raise Breast Cancer Risk 2Health News:Common Household Chemical Could Raise Breast Cancer Risk 3Health News:This is your brain on violent media 2Health News:Emisphere Names Adam Friedman Associates IR Agency of Record 2Health News:Emisphere Names Adam Friedman Associates IR Agency of Record 3Health News:Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference 2Health News:Proteolix Announces Clinical Results With Carfilzomib to be Reported at ASH 2007 Annual Meeting 2Health News:SGX Pharmaceuticals BCR-ABL Program to be Presented at the American Society of Hematology 49th Annual Meeting and Exposition 2Health News:SGX Pharmaceuticals BCR-ABL Program to be Presented at the American Society of Hematology 49th Annual Meeting and Exposition 3Health News:SGX Pharmaceuticals BCR-ABL Program to be Presented at the American Society of Hematology 49th Annual Meeting and Exposition 4
(Date:7/25/2014)... July 25, 2014  CVS Caremark Corporation (NYSE: ... on Tuesday, August 5, 2014, at 8:30 a.m. (EDT) ... 2014 financial results. An audio webcast of ... Investor Relations portion of the CVS Caremark website for ... http://info.cvscaremark.com/investors . This webcast will be archived and available ...
(Date:7/25/2014)... , July 25, 2014  The Chemistry, Food ... Ministry of Health approved the introduction of Telaprevir ... the cure rate from Hepatitis C, and it ... 1 virus. Telaprevir is available in ... Photo - http://www2.prnewswire.com.br/imgs/pub/2014-07-25/original/2026.jpg   ...
(Date:7/25/2014)... , July 25, 2014  Acsis Inc., ... protection and serialization solutions, has recently posted an ... that addresses current and future needs for companies, ... the old supply chain model no longer work ... technology, including the growth of mobile technology, machine ...
Breaking Medicine Technology:The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3Acsis Addresses Questions on the Modern Supply Chain 2
... WIRE)--Jun 19, 2007 - Javelin,Pharmaceuticals (AMEX: JAV) ... morphine) successfully met its,primary clinical endpoint, the ... over 0-24 hours postoperatively. In this first ... moderate-to-severe pain,after elective orthopedic surgery were given ...
... --,Nuvelo, Inc. today announced the publication of the ... rNAPc2,To Help Eliminate MACE)/TIMI 32 clinical trial (N=255) ... of Cardiology (JACC), demonstrating,that higher-dose (greater than or ... (rNAPc2) reduced the incidence,and duration of ischemia as ...
Cached Medicine Technology:Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 2Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 3Javelin Pharmaceuticals Announces Successful Pivotal Phase 3 Trial,Data 4Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in,Journal of American College of Cardiology 2Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in,Journal of American College of Cardiology 3Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in,Journal of American College of Cardiology 4
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
Medicine Products: